韩国多中心电子健康记录主动药物警戒框架的构建与应用
通过分布式查询和荟萃分析发现,NSAIDs较阿司匹林使消化道出血风险增加约两倍,非维生素K拮抗剂抗凝药较华法林使脑血管出血风险降低至0.18倍。结果表明K-CDM用于药物警戒具有可行性,但原始数据质量、映射完整性和机构异质性限制了分析有效性。
要点
- K-CDM整合13家机构约540万患者数据,支持分布式药物警戒分析
- NSAIDs较阿司匹林使消化道出血风险增加约两倍
- 非维生素K拮抗剂抗凝药较华法林使脑血管出血风险降低至0.18倍
核心结论
- K-CDM用于药物警戒具有可行性,分析结果与既往研究相似。
- 原始电子病历数据质量低、映射不完整和机构间异质性降低了分析有效性。
研究设计与样本
- 基于韩国13家机构去标识化电子健康记录构建专用K-CDM,纳入患者记录n=5,402,129。
- 2005至2017年共记录37,698,535次就诊、39,910,849条病症、259,594,727次药物暴露和30,176,929次操作。
- K-CDM含三层结构,兼容现有模型,采用标准词汇映射诊断、处方和操作编码。
- 基于临床场景开发分布式查询,通过去中心化或分布式网络应用于K-CDM。
- 对十家机构的药物相对风险比进行荟萃分析。
主要发现
- 荟萃分析显示NSAIDs较阿司匹林使消化道出血风险增加约两倍。
- 非维生素K拮抗剂抗凝药较华法林使脑血管出血风险降低至0.18倍。
临床怎么用
- 可利用K-CDM分布式网络开展多中心药物不良反应主动监测。
- 分析结果需结合原始数据质量和机构异质性谨慎解读。
局限性
- 原始电子病历数据质量低。
- 编码映射不完整。
- 机构间存在异质性,降低分析有效性。
- 需研究者、临床医生和政府持续校准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: With the availability of retrospective pharmacovigilance data, the common data model (CDM) has been identified as an efficient approach towards anonymized multicenter analysis; however, the establishment of a suitable model for individual medical systems and applications supporting their analysis is a challenge. OBJECTIVE: The aim of this study was to construct a specialized Korean CDM (K-CDM) for pharmacovigilance systems based on a clinical scenario to detect adverse drug reactions (ADRs). METHODS: De-identified patient records (n = 5,402,129) from 13 institutions were converted to the K-CDM. From 2005 to 2017, 37,698,535 visits, 39,910,849 conditions, 259,594,727 drug exposures, and 30,176,929 procedures were recorded. The K-CDM, which comprises three layers, is compatible with existing models and is potentially adaptable to extended clinical research. Local codes for electronic medical records (EMRs), including diagnosis, drug prescriptions, and procedures, were mapped using standard vocabulary. Distributed queries based on clinical scenarios were developed and applied to K-CDM through decentralized or distributed networks. RESULTS: Meta-analysis of drug relative risk ratios from ten institutions revealed that non-steroidal anti-inflammatory drugs (NSAIDs) increased the risk of gastrointestinal hemorrhage by twofold compared with aspirin, and non-vitamin K anticoagulants decreased cerebrovascular bleeding risk by 0.18-fold compared with warfarin. CONCLUSION: These results are similar to those from previous studies and are conducive for new research, thereby demonstrating the feasibility of K-CDM for pharmacovigilance. However, the low quality of original EMR data, incomplete mapping, and heterogeneity between institutions reduced the validity of the analysis, thus necessitating continuous calibration among researchers, clinicians, and the government.
引用
- Choe S, Lee S, Park CH, et al. Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea. Drug Saf. 2023. PMID: 37243963. doi:10.1007/s40264-023-01296-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。